VENKATARAMANI CHANDRASEKAR,METOBO SAMUEL E,KIM CHOUNG U
申请号：
AP201608993
公开号：
AP201608993A0
申请日:
2010.05.12
申请国别(地区):
AP
年份:
2016
代理人:
摘要：
The invention provides a pharmaceutical composition comprising: (1) a compound of the formula: or a pharmaceutically acceptable salt thereof； (2) a NS5B polymerase inhibitor； and (3) a NS3 protease inhibitor； and relates to the use of (1), (2) and (3), in combination, in the prophylactic or therapeutic treatment of hepatitis C or a hepatitis C associated disorder.
